Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. (Q39737918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

meta-analysis

0 references

title

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

0 references

1 reference

neoadjuvant chemotherapy

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Mark Smithers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

4

John R Zalcberg

2 references

ORCID Public Data File 2021

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Bryan H Burmeister

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

R John Simes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Andrew Barbour

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Val Gebski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Australasian Gastro-Intestinal Trials Group

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

16 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

681-692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Preoperative radiotherapy for esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Induction chemotherapy in the treatment of patients with carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Prospective evaluation of preoperative chemotherapy in resectable squamous cell carcinoma of the thoracic esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Models for estimating the number of unpublished studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Neoadjuvant chemoradiotherapy for esophageal cancer: a review of meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

Prognostic factors and patterns of recurrence in esophageal cancer assert arguments for extended two-field transthoracic esophagectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970142-5

7 January 2021

10.1016/S1470-2045(11)70142-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21684205%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference